
Intuitive Surgical (ISRG) received a 77% rating from Validea's Growth Investor model, based on Martin Zweig's strategy, which seeks growth stocks with accelerating earnings and sales, reasonable valuations, and low debt. Although ISRG demonstrated strong revenue and EPS growth, it failed criteria related to its P/E ratio and earnings persistence, placing it just below the 80% threshold for "some interest" according to the model.
Based on Validea's quantitative analysis using the Martin Zweig growth model, Intuitive Surgical, Inc. (ISRG) presents a mixed but largely positive fundamental picture, scoring 77%. This places the company just below the 80% threshold that typically signifies model interest. ISRG demonstrates strong current momentum, passing key criteria for current quarter earnings, sales growth rate, and a positive debt-to-equity ratio. Notably, its current quarter EPS growth successfully surpassed both the average of the prior three quarters and its historical growth rate, indicating significant near-term acceleration. However, the model flagged critical weaknesses that prevented a higher score. The company failed the P/E ratio test, suggesting its valuation may be stretched according to the Zweig framework. Furthermore, it failed on measures of 'earnings persistence' and 'earnings growth rate for the past several quarters', highlighting that while the most recent quarter was strong, the pattern of accelerating growth has not been consistent over a longer period.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment